Introduction of new pediatric EBMT criteria for VOD diagnosis: is it time-saving or money-wasting? Prospective evaluation of pediatric EBMT criteria for VOD
Z Szmit, E Gorczynska, A Król, M Ussowicz… - Bone Marrow …, 2020 - nature.com
Hepatic veno-occlusive disease (VOD) is a potentially fatal complication following
hematopoietic stem cell transplantation (HSCT). We evaluated in prospective analysis the …
hematopoietic stem cell transplantation (HSCT). We evaluated in prospective analysis the …
Neutrophilic granule protein (NGP) attenuates lipopolysaccharide-induced inflammatory responses and enhances phagocytosis of bacteria by macrophages
K Liu, L Tian, X Tang, J Wang, W Tang, Z Ma, T Chen… - Cytokine, 2020 - Elsevier
Neutrophilic granule protein (NGP) belongs to the cystatin superfamily. Even though this
superfamily is critically involved in cancer biology and adaptive immunity, the relationship of …
superfamily is critically involved in cancer biology and adaptive immunity, the relationship of …
Hepatobiliary disease after bone marrow transplant
MGF Dezan, LN Cavalcante, HP Cotrim… - Expert Review of …, 2023 - Taylor & Francis
Introduction Bone marrow transplantation (BMT) is the standard treatment for several
hematologic pathologies. Post-BMT patients may develop hepatobiliary complications that …
hematologic pathologies. Post-BMT patients may develop hepatobiliary complications that …
Renal and hepatic health after childhood cancer
MJ Ehrhardt, R Skinner, SM Castellino - Pediatric Clinics, 2020 - pediatric.theclinics.com
Approximately two-thirds of childhood cancer survivors (CCSs) experience at least 1 chronic
health condition, 1 among which are long-term and/or late-occurring renal and hepatic …
health condition, 1 among which are long-term and/or late-occurring renal and hepatic …
Shear wave elastography in the detection of sinusoidal obstruction syndrome in adult patients undergoing allogenic hematopoietic stem cell transplantation
M Schulz, LG Vuong, HP Müller, M Maibier, F Tacke… - Diagnostics, 2021 - mdpi.com
Hepatic sinusoidal obstruction syndrome (SOS), also known as veno-occlusive disease
(VOD) can be a life-threatening complication after hematopoietic stem cell transplantation …
(VOD) can be a life-threatening complication after hematopoietic stem cell transplantation …
TNF-α indicates radiation-induced liver injury after interstitial high dose-rate brachytherapy
R Damm, M Pech, F Haag, P Cavalli, S Gylstorff… - in vivo, 2022 - iv.iiarjournals.org
Abstract Background/Aim: The aim of the present study was to determine whether the early
systemic markers of inflammation, interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α) …
systemic markers of inflammation, interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α) …
[HTML][HTML] Post-transplantation sinusoidal obstruction syndrome in adult patients with B cell acute lymphoblastic leukemia treated with pretransplantation inotuzumab
V Agrawal, H Pourhassan, NC Tsai, D Ngo… - … and Cellular Therapy, 2023 - Elsevier
Sinusoidal obstruction syndrome (SOS) is a potentially life-threatening complication that can
be observed after allogeneic hematopoietic cell transplantation (HCT). Inotuzumab …
be observed after allogeneic hematopoietic cell transplantation (HCT). Inotuzumab …
Pre-exposure to defibrotide prevents endothelial cell activation by lipopolysaccharide: an ingenuity pathway analysis
N Orlando, G Babini, P Chiusolo, CG Valentini… - Frontiers in …, 2020 - frontiersin.org
Defibrotide (DFB) effects on different endothelial cell pathways have been investigated
focusing on a limited number of genes or molecules. This study explored the modulation of …
focusing on a limited number of genes or molecules. This study explored the modulation of …
[HTML][HTML] Evaluation of children with malignancies for blood and marrow transplantation: a report from the ASTCT Committee on Practice Guidelines
Evaluation of a candidate for hematopoietic cell transplantation (HCT) is a complex process
with substantial intercenter variability. Although literature providing guidance for evaluating …
with substantial intercenter variability. Although literature providing guidance for evaluating …
[HTML][HTML] Elevation of early plasma biomarkers in patients with clinical risk factors predicts increased nonrelapse mortality after allogeneic hematopoietic stem cell …
M Hotta, A Satake, H Yoshimura, S Fujita… - … and Cellular Therapy, 2021 - Elsevier
Early prediction of nonrelapse mortality (NRM) in patients undergoing allogeneic
hematopoietic stem cell transplantation (allo-HSCT) based on the results of laboratory tests …
hematopoietic stem cell transplantation (allo-HSCT) based on the results of laboratory tests …